|
|
Post by zar on May 16, 2009 17:41:58 GMT -5
Acquisition of Zephyr(R) EBV Technology Enables Pulmonx to Develop Both Assessment Tools and Therapeutic Solutions for Emphysema PALO ALTO, Calif., May 13 /PRNewswire/ -- Pulmonx, a medical device company focused on advancing therapies for patients with emphysema, announced today that it has acquired all of the assets of Emphasys Medical, including its endobronchial valve (EBV) technology platform and associated intellectual property. Pulmonx has now assumed global sales, marketing, customer support, and future development programs of the Emphasys(R) EBV (formerly known as Zephyr(R) EBV). (more) www.earthtimes.org/articles/show/pu...ys,823154.shtml |
|
